Overview

Treating Chronic Insomnia in Breast Cancer Patients

Status:
Terminated
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to evaluate the effectiveness of ramelteon 8mgs in the treatment of insomnia in patients that have completed their first chemotherapy treatment for breast cancer.
Phase:
Phase 4
Details
Lead Sponsor:
Accelerated Community Oncology Research Network
Collaborator:
Takeda Pharmaceuticals North America, Inc.